Bradley & Co Private Wealth Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.52K	Hold	370	–	–	﹤0.01%	170
2025 Q4	$2.89K	Buy	+370	New	+$2.67K	﹤0.01%	176
2023 Q4	–	Sell	-370	Closed	-$2.62K	–	199
2023 Q3	$2.62K	Hold	370	–	–	﹤0.01%	150
2023 Q2	$2.6K	Hold	370	–	–	﹤0.01%	153
2023 Q1	$3.09K	Hold	370	–	–	﹤0.01%	147
2022 Q4	$4.25K	Hold	370	–	–	0.01%	141
2022 Q3	$5K	Hold	370	–	–	0.01%	141
2022 Q2	$4K	Hold	370	–	–	﹤0.01%	152
2022 Q1	$6K	Hold	370	–	–	0.01%	133
2021 Q4	$5K	Hold	370	–	–	﹤0.01%	138
2021 Q3	$5K	Hold	370	–	–	﹤0.01%	144
2021 Q2	$6K	Hold	370	–	–	0.01%	149
2021 Q1	$4K	Buy	+370	New	+$3.81K	﹤0.01%	152